Stocksigma LogoStocksigma Logo

Amerise Biosciences Approves Financial Statements and Appoints Whole-time Director and CFO

Amerise Biosciences Limited transacted and approved key resolutions at its 41st Annual General Meeting held on 24th Sep'26

Amerise Biosciences Approves Financial Statements and Appoints Whole-time Director and CFO

Amerise Biosciences Ltd 路 Annual General Meeting 路 24 Sept 2026, 9:57 pm

Amerise Biosciences Approves Financial Statements and Appoints Whole-time Director and CFO Amerise Biosciences Limited transacted and approved key resolutions at its 41st Annual General Meeting held on 24th Sep'26. Shareholders approved the adoption of audited financial statements for the financial year ended 31st Mar'26, along with reports from directors and auditors. Additionally, shareholders cleared an ordinary resolution appointing Mr. Albert Hines (DIN: 10742692) as Whole-time Director and Chief Financial Officer of the company. Detailed voting results under Regulation 44(3) are being submitted separately.

Original exchange filing (PDF)

More announcements from Amerise Biosciences Ltd

All Amerise Biosciences Ltd announcements